Dugel Pravin Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$647,412.19

Insider Activity of Dugel Pravin

According to the SEC Form 4 filings, Dugel Pravin, being in a position of

  1. See Remarks at Ocular Therapeutix, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 207273 shares for $1.94M,
    over all time since 2024-05-23, has bought 0 shares, and sold 334647 shares for $3M.

Biography of Dugel Pravin

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,936,7775100

Comparison of Insiders on Amount of Buys and Sells

2026-08-24SaleOcular Therapeutix, Inc.
OCUL
See Remarks
21,649
0.0096%
$10.77$233,160-28.9%
2026-05-26SaleOcular Therapeutix, Inc.
OCUL
See Remarks
21,156
0.0093%
$8.20$173,479+9.53%
2026-02-23SaleOcular Therapeutix, Inc.
OCUL
See Remarks
20,056
0.0091%
$8.28$166,064+7.97%
2026-02-12SaleOcular Therapeutix, Inc.
OCUL
See Remarks
124,882
0.0572%
$9.04$1.13M-1.05%
2025-11-24SaleOcular Therapeutix, Inc.
OCUL
See Remarks
19,530
0.0111%
$12.04$235,141-22.07%
2025-08-25SaleOcular Therapeutix, Inc.
OCUL
See Remarks
21,494
0.0121%
$12.04$258,788-14.91%
2025-05-23SaleOcular Therapeutix, Inc.
OCUL
See Remarks
21,219
0.0131%
$7.18$152,352+51.58%
2025-02-24SaleOcular Therapeutix, Inc.
OCUL
See Remarks
21,475
0.0134%
$6.87$147,533+64.34%
2024-11-25SaleOcular Therapeutix, Inc.
OCUL
See Remarks
20,680
0.013%
$9.01$186,327-1.76%
2024-08-23SaleOcular Therapeutix, Inc.
OCUL
See Remarks
20,880
0.0133%
$9.02$188,338-4.72%
2024-05-23SaleOcular Therapeutix, Inc.
OCUL
See Remarks
21,626
0.0139%
$5.79$125,215+38.79%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.